Recent advancements in cholangiocarcinoma (CCA) research have been marked by the innovative use of three-dimensional multicellular spheroid (3D MCS) models. These models, which replicate the 3D architecture and multicellular...                                     
                                        
                                        
                                                                                
                                      
                                   
                                            Photo by Kitt_KS   Cholangiocarcinoma (CCA), a type of liver cancer, is driven by oxidative stress and chronic inflammation. Researchers from Khon Kaen University have made a significant breakthrough by...                                     
                                        
                                        
                                                                                
                                      
                                   
                                            Photo by Martin Lopez/pexels  A groundbreaking study uncovers a potential target for therapeutic intervention in cholangiocarcinoma (CCA), a highly aggressive form of liver cancer. Researchers have identified elevated expression...                                     
                                        
                                        
                                                                                
                                      
                                   
                                            Photo by Chokniti Khongchum/pexels   Cholangiocarcinoma (CCA), a form of liver cancer, has long posed challenges in treatment due to its genetic complexity. However, a recent study published in PeerJ has shed...                                     
                                        
                                        
                                                                                
                                      
                                   
                                            A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy. The study aimed...                                     
                                        
                                        
                                                                                
                                      
                                


 
                                       
                                       
                                       
                                      